Bechtel Medical Revenue

About Bechtel Medical

Bechtel Medical, Inc. is a medical device startup committed to advancing wound care through innovation, engineering excellence, and a focus on patient outcomes. With multiple patents in our portfolio, we are positioned to bring novel technologies to market efficiently while upholding the highest standards of safety, quality, and compliance. We believe innovation in medical devices is essential to transforming healthcare and improving lives. Our mission is to address critical unmet needs by developing technologies that empower clinicians, support patients, and advance the quality of care worldwide. Breakthrough solutions must be both cutting-edge and practical—designed not just to meet regulatory requirements, but to integrate seamlessly into clinical workflows and deliver measurable results in real-world settings. Our founder, John M. Gvodas, Jr., is a seasoned healthcare entrepreneur with more than 25 years of leadership experience. He founded and served as President of Adapt Health Corp., which grew through 60 acquisitions and strong organic expansion before going public in 2019 via a SPAC merger. Today, Adapt Health (NASDAQ: AHCO) is among the largest DMEPOS providers in the nation, with 700 locations across 48 states. Today, Bechtel Medical, Inc., under the leadership of Mr. Gvodas and a dedicated team of engineers and clinicians, is completing development of a novel, integrated wound care system with an anticipated launch in 2026. The company’s patented technology, designed to address complex wounds, is expected to be a disruptive force in the $30 billion global wound care market. As a growing company, we embrace collaboration, agility, and excellence as the foundation of everything we do. Our team of engineers, regulatory experts, and clinicians share a passion for transforming care and building healthier communities. At Bechtel Medical, we are not just building devices—we are building the future of wound care.

View contact profiles from Bechtel Medical